Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients

Author:

Masuda Norikazu,Inoue Kenichi,Nakamura Rikiya,Rai Yoshiaki,Mukai Hirofumi,Ohno Shinji,Hara Fumikata,Mori Yuko,Hashigaki Satoshi,Muramatsu Yasuaki,Nagasawa Takashi,Umeyama Yoshiko,Huang Xin,Iwata Hiroji

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Reference22 articles.

1. World Health Organization (2018) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 20 Mar 2018

2. Sung H, Rosenberg PS, Chen WQ et al (2015) Female breast cancer incidence among Asian and Western populations: more similar than expected. J Natl Cancer Inst 107(7):[Epub]. https://doi.org/10.1093/jnci/djv107

3. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

4. National Comprehensive Cancer Network (2018) Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Breast Cancer. Version 1. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf . Accessed 9 Apr 2018

5. Fry DW, Harvey PJ, Keller PR et al (2004) Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 3(11):1427–1438

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3